167 related articles for article (PubMed ID: 22151793)
41. Photodynamic therapy--aspects of pain management.
Fink C; Enk A; Gholam P
J Dtsch Dermatol Ges; 2015 Jan; 13(1):15-22. PubMed ID: 25640485
[TBL] [Abstract][Full Text] [Related]
42. Laser-mediated photodynamic therapy of actinic keratoses.
Alexiades-Armenakas MR; Geronemus RG
Arch Dermatol; 2003 Oct; 139(10):1313-20. PubMed ID: 14568836
[TBL] [Abstract][Full Text] [Related]
43. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses.
Langan SM; Collins P
Br J Dermatol; 2006 Jan; 154(1):146-9. PubMed ID: 16403108
[TBL] [Abstract][Full Text] [Related]
44. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
45. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
46. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
47. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.
Willey A; Mehta S; Lee PK
Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154
[TBL] [Abstract][Full Text] [Related]
48. Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis.
Middelburg TA; Kanick SC; de Haas ER; Sterenborg HJ; Amelink A; Neumann MH; Robinson DJ
J Biophotonics; 2011 Oct; 4(10):721-30. PubMed ID: 21842485
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis.
Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T
Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912
[TBL] [Abstract][Full Text] [Related]
50. [Organ transplant recipients need intensive control and treatment of skin cancer].
Togsverd-Bo K; Sørensen SS; Hædersdal M
Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
[TBL] [Abstract][Full Text] [Related]
51. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial.
Babilas P; Knobler R; Hummel S; Gottschaller C; Maisch T; Koller M; Landthaler M; Szeimies RM
Br J Dermatol; 2007 Jul; 157(1):111-7. PubMed ID: 17542980
[TBL] [Abstract][Full Text] [Related]
52. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
53. Cold air analgesia as pain reduction during photodynamic therapy of actinic keratoses.
Stangeland KZ; Kroon S
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):849-54. PubMed ID: 21707775
[TBL] [Abstract][Full Text] [Related]
54. Guidelines for topical photodynamic therapy: update.
Morton CA; McKenna KE; Rhodes LE;
Br J Dermatol; 2008 Dec; 159(6):1245-66. PubMed ID: 18945319
[TBL] [Abstract][Full Text] [Related]
55. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
56. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure.
Terhorst D; Drecoll U; Stockfleth E; Ulrich C
Br J Dermatol; 2009 Nov; 161 Suppl 3():85-9. PubMed ID: 19775362
[TBL] [Abstract][Full Text] [Related]
57. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
[TBL] [Abstract][Full Text] [Related]
58. Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
Jambusaria-Pahlajani A; Ortman S; Schmults CD; Liang C
Dermatol Surg; 2016 Jan; 42 Suppl 1():S66-72. PubMed ID: 26730976
[TBL] [Abstract][Full Text] [Related]
59. Conventional treatment of actinic keratosis: an overview.
Peris K; Fargnoli MC
Curr Probl Dermatol; 2015; 46():108-14. PubMed ID: 25561214
[TBL] [Abstract][Full Text] [Related]
60. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
